Kardigan: Funding, Investors & Team (Sep 2026)
Kardigan is a heart health company that is changing the way cardiovascular medications are developed by focusing on patient needs, aiming to create drugs that go beyond just managing symptoms to actually curing the condition.
Kardigan has raised $554M across 2 funding rounds on record, the most recent a Series B of $254M announced in Oct 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kardigan Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Kardigan Funding Rounds
Kardigan raised $300M in a Series A announced in Jan 2025.
9 months later, a Series B of $254M was announced in Oct 2025.
Kardigan Founders and Leadership Team
Contact details for the Kardigan team: 2 of 3 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Kardigan Funding Compared to Other Biotechnology Startups
Kardigan's latest round of $254M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kardigan in Biotechnology and South San Francisco
Companies Similar to Kardigan
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Kardigan Funding FAQs
What does Kardigan do?
Kardigan is a heart health company that is changing the way cardiovascular medications are developed by focusing on patient needs, aiming to create drugs that go beyond just managing symptoms to actually curing the condition.
How much funding has Kardigan raised?
Kardigan has raised $554M across 2 rounds on record. The most recent is a Series B of $254M announced in Oct 2025.
When did Kardigan last raise funding?
Kardigan's most recent funding round on record is a Series B of $254M, announced in Oct 2025.
Who founded Kardigan?
FundedIQ lists Bob Mcdowell (Founder), Jay Edelberg (Founder) at Kardigan.
Who is the CEO of Kardigan?
Tassos Gianakakos is listed as CEO at Kardigan.
Where is Kardigan headquartered?
Kardigan is based in South San Francisco, California, United States.
How many employees does Kardigan have?
Kardigan is in the 51-100 employee band.
How does Kardigan's funding compare to other Biotechnology startups?
Kardigan's latest round of $254M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Kardigan Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kardigan is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.